• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A resample-replace lasso procedure for combining high-dimensional markers with limit of detection.一种用于结合具有检测限的高维标记物的重采样替换套索方法。
J Appl Stat. 2021 Sep 22;49(16):4278-4293. doi: 10.1080/02664763.2021.1977785. eCollection 2022.
2
Estimating the AUC with a Graphical Lasso Method for High-dimensional Biomarkers with LOD.使用图形套索法估计具有检测限的高维生物标志物的AUC。
Biostat Epidemiol. 2021;5(2):189-206. doi: 10.1080/24709360.2021.1898731. Epub 2021 Mar 17.
3
Combining markers with and without the limit of detection.结合有和无检测限的标志物。
Stat Med. 2014 Apr 15;33(8):1307-20. doi: 10.1002/sim.6027. Epub 2013 Oct 17.
4
Lasso regularization for left-censored Gaussian outcome and high-dimensional predictors.左截断高斯结局和高维预测因子的套索正则化。
BMC Med Res Methodol. 2018 Dec 4;18(1):159. doi: 10.1186/s12874-018-0609-4.
5
Youden Index and optimal cut-point estimated from observations affected by a lower limit of detection.由受检测下限影响的观测值估计的尤登指数和最佳切点。
Biom J. 2008 Jun;50(3):419-30. doi: 10.1002/bimj.200710415.
6
Bootstrap-based testing approaches for the assessment of the diagnostic accuracy of biomarkers subject to a limit of detection.基于引导的检测方法在可检测限下评估生物标志物的诊断准确性。
Stat Methods Med Res. 2019 May;28(5):1564-1578. doi: 10.1177/0962280218769334. Epub 2018 Apr 11.
7
Application of fused graphical lasso to statistical inference for multiple sparse precision matrices.融合图形套索在多个稀疏精度矩阵的统计推断中的应用。
PLoS One. 2024 May 31;19(5):e0304264. doi: 10.1371/journal.pone.0304264. eCollection 2024.
8
The joint graphical lasso for inverse covariance estimation across multiple classes.用于跨多个类别的逆协方差估计的联合图形套索法。
J R Stat Soc Series B Stat Methodol. 2014 Mar;76(2):373-397. doi: 10.1111/rssb.12033.
9
Probability genotype imputation method and integrated weighted lasso for QTL identification.概率基因型推断方法和集成加权套索用于 QTL 鉴定。
BMC Genet. 2013 Dec 30;14:125. doi: 10.1186/1471-2156-14-125.
10
New insights into modeling exposure measurements below the limit of detection.低于检测限的暴露测量建模新见解。
Environ Epidemiol. 2020 Dec 16;5(1):e116. doi: 10.1097/EE9.0000000000000116. eCollection 2021 Feb.

引用本文的文献

1
Prognostic Significance of Soluble PD-L1 on Cardiovascular Outcomes in Patients with Coronary Artery Disease.可溶性 PD-L1 对冠心病患者心血管结局的预后意义。
J Atheroscler Thromb. 2024 Apr 1;31(4):355-367. doi: 10.5551/jat.64183. Epub 2023 Oct 3.

本文引用的文献

1
ℓ 1-Penalized censored Gaussian graphical model.L1 惩罚截断高斯图形模型。
Biostatistics. 2020 Apr 1;21(2):e1-e16. doi: 10.1093/biostatistics/kxy043.
2
Sufficient dimension reduction for censored predictors.删失预测变量的充分降维
Biometrics. 2017 Mar;73(1):220-231. doi: 10.1111/biom.12556. Epub 2016 Aug 9.
3
Nonsurgical treatment of recurrent glioblastoma.复发性胶质母细胞瘤的非手术治疗
Curr Oncol. 2015 Aug;22(4):e273-81. doi: 10.3747/co.22.2436.
4
Combining markers with and without the limit of detection.结合有和无检测限的标志物。
Stat Med. 2014 Apr 15;33(8):1307-20. doi: 10.1002/sim.6027. Epub 2013 Oct 17.
5
Penalized classification using Fisher's linear discriminant.使用费舍尔线性判别法的惩罚分类
J R Stat Soc Series B Stat Methodol. 2011 Nov;73(5):753-772. doi: 10.1111/j.1467-9868.2011.00783.x.
6
ROC curve inference for best linear combination of two biomarkers subject to limits of detection.受检测限影响的两种生物标志物最佳线性组合的ROC曲线推断
Biom J. 2011 May;53(3):464-76. doi: 10.1002/bimj.201000083.
7
Differential retinoic acid signaling in tumors of long- and short-term glioblastoma survivors.长期和短期胶质母细胞瘤幸存者肿瘤中差异的视黄酸信号转导。
J Natl Cancer Inst. 2011 Apr 6;103(7):598-606. doi: 10.1093/jnci/djr036. Epub 2011 Feb 23.
8
Combined use of wild-type HBV precore and high serum iron marker as a potential tool for the prediction of cirrhosis in chronic hepatitis B infection.联合使用野生型 HBV 前核心区和高血清铁标志物作为预测慢性乙型肝炎感染患者肝硬化的潜在工具。
J Med Virol. 2011 Apr;83(4):594-601. doi: 10.1002/jmv.22016.
9
Measurement of biomarker proteins for point-of-care early detection and monitoring of cancer.用于即时检测和监测癌症的生物标志物蛋白的测量。
Analyst. 2010 Oct;135(10):2496-511. doi: 10.1039/c0an00204f. Epub 2010 Jul 8.
10
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.同步放化疗联合辅助替莫唑胺与单纯放疗对胶质母细胞瘤生存影响的随机III期研究:EORTC-NCIC试验的5年分析
Lancet Oncol. 2009 May;10(5):459-66. doi: 10.1016/S1470-2045(09)70025-7. Epub 2009 Mar 9.

一种用于结合具有检测限的高维标记物的重采样替换套索方法。

A resample-replace lasso procedure for combining high-dimensional markers with limit of detection.

作者信息

Wang Jinjuan, Zhao Yunpeng, Tang Larry L, Mueller Claudius, Li Qizhai

机构信息

School of Mathematics and Statistics, Beijing Institute of Technology, Beijing, People's Republic of China.

School of Mathematical and Natural Sciences, Arizona State University, Tempe, AZ, USA.

出版信息

J Appl Stat. 2021 Sep 22;49(16):4278-4293. doi: 10.1080/02664763.2021.1977785. eCollection 2022.

DOI:10.1080/02664763.2021.1977785
PMID:36353301
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9639487/
Abstract

In disease screening, a biomarker combination developed by combining multiple markers tends to have a higher sensitivity than an individual marker. Parametric methods for marker combination rely on the inverse of covariance matrices, which is often a non-trivial problem for high-dimensional data generated by modern high-throughput technologies. Additionally, another common problem in disease diagnosis is the existence of limit of detection (LOD) for an instrument - that is, when a biomarker's value falls below the limit, it cannot be observed and is assigned an NA value. To handle these two challenges in combining high-dimensional biomarkers with the presence of LOD, we propose a resample-replace lasso procedure. We first impute the values below LOD and then use the graphical lasso method to estimate the means and precision matrices for the high-dimensional biomarkers. The simulation results show that our method outperforms alternative methods such as either substitute NA values with LOD values or remove observations that have NA values. A real case analysis on a protein profiling study of glioblastoma patients on their survival status indicates that the biomarker combination obtained through the proposed method is more accurate in distinguishing between two groups.

摘要

在疾病筛查中,通过组合多个标志物开发的生物标志物组合往往比单个标志物具有更高的灵敏度。用于标志物组合的参数方法依赖于协方差矩阵的逆,这对于现代高通量技术生成的高维数据来说通常是一个棘手的问题。此外,疾病诊断中的另一个常见问题是仪器存在检测限(LOD)——也就是说,当生物标志物的值低于该限时,就无法观察到,并且会被赋值为NA值。为了应对在存在LOD的情况下组合高维生物标志物时的这两个挑战,我们提出了一种重采样替换套索程序。我们首先对低于LOD的值进行插补,然后使用图形套索方法来估计高维生物标志物的均值和精度矩阵。模拟结果表明,我们的方法优于其他方法,如用LOD值替代NA值或删除具有NA值的观测值。对胶质母细胞瘤患者生存状态的蛋白质谱研究进行的实际案例分析表明,通过所提出的方法获得的生物标志物组合在区分两组时更准确。